mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.005 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.005 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.005 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.007 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |